Cover Image

Extended Infusion of Meropenem in Neonatal Sepsis: A Historical Cohort Study

This single-center historical cohort study investigated the effectiveness and safety of extended infusion (EI) compared with short-term infusion (STI) of meropenem in neonatal sepsis. Patient electronic health records from Peking University Third Hospital (1 December 2011-1 April 2021) were screened...

Full description

Saved in:

Bibliographic Details
Main Authors:	Guangna Cao (Author), Pengxiang Zhou (Author), Hua Zhang (Author), Bangkai Sun (Author), Xiaomei Tong (Author), Yan Xing (Author)
Format:	Book
Published:	MDPI AG, 2022-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China
by: Pengxiang Zhou, et al.
Published: (2022)

Extended or Continuous Infusion of Carbapenems in Children with Severe Infections: A Systematic Review and Narrative Synthesis
by: Pengxiang Zhou, et al.
Published: (2021)

Clinical Challenge: Standard Versus Extended Meropenem Infusion in Children
by: Ahmet Erhan Kişi, et al.
Published: (2024)

Pharmacokinetics and Pharmacodynamics of Meropenem by Extended or Continuous Infusion in Low Body Weight Critically Ill Patients
by: Sonia Luque, et al.
Published: (2021)

A Retrospective Analysis of Intravenous Push versus Extended Infusion Meropenem in Critically Ill Patients
by: Emory G. Johnson, et al.
Published: (2024)

Extended Versus Intermittent Meropenem Infusion in the Treatment of Nosocomial Pneumonia: A Retrospective Single-Center Study
by: Dong-gon Hyun, et al.
Published: (2023)

An investigation of the stability of meropenem in elastomeric infusion devices
by: Foy F, et al.
Published: (2019)

Developmental Population Pharmacokinetics-Pharmacodynamics of Meropenem in Chinese Neonates and Young Infants: Dosing Recommendations for Late-Onset Sepsis
by: Yue-E Wu, et al.
Published: (2022)

Cefepime extended infusion versus intermittent infusion: Clinical and cost evaluation
by: Aalok V. Khole, et al.
Published: (2023)

Erratum: The OBTAINS study: A nationwide cross-sectional survey on the implementation of extended or continuous infusion of β-lactams and vancomycin among neonatal sepsis patients in China
by: Frontiers Production Office
Published: (2022)

Cerebrospinal Fluid Concentrations of Meropenem and Vancomycin in Ventriculitis Patients Obtained by TDM-Guided Continuous Infusion
by: Christoph Tiede, et al.
Published: (2021)

Extended infusion versus intermittent infusion of imipenem in the treatment of ventilator-associated pneumonia
by: Ibrahim MM, et al.
Published: (2017)

Risk factors and prognosis for neonatal sepsis in southeastern Mexico: analysis of a four-year historic cohort follow-up
by: Leal Yelda A, et al.
Published: (2012)

First case report of a vertebral osteomyelitis caused by carbapenem-resistant Enterobacter cloacae treated with imipenem/cilastatin/relebactam prolonged infusion then meropenem/vaborbactam in continuous infusion
by: Paul Laffont-Lozes, et al.
Published: (2024)

Optimizing Antibiotic Treatment Strategies for Neonates and Children: Does Implementing Extended or Prolonged Infusion Provide any Advantage?
by: Paola Costenaro, et al.
Published: (2020)

Extended Infusion of Dexmedetomidine to an Infant at Sixty Times the Intended Rate
by: Bryan A. Max, et al.
Published: (2010)

Late-onset neonatal sepsis in Suzhou, China
by: Tao Pan, et al.
Published: (2020)

Influence of Concentration and Temperature on Stability of Imipenem Focused on Solutions for Extended Infusion
by: Chuleegone Sornsuvit, et al.
Published: (2021)

Model-Informed Translation of In Vitro Effects of Short-, Prolonged- and Continuous-Infusion Meropenem against <em>Pseudomonas aeruginosa</em> to Clinical Settings
by: Iris K. Minichmayr, et al.
Published: (2022)

Carbapenem-Resistant Enterobacteriaceae Bloodstream Infection Treated Successfully With High-Dose Meropenem in a Preterm Neonate
by: Yue-E Wu, et al.
Published: (2020)

Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections
by: Pasquale Maria Berrino, et al.
Published: (2023)

Defining Exposure Predictors of Meropenem That Are Associated with Improved Survival for Severe Bacterial Infection: A Preclinical PK/PD Study in Sepsis Rat Model
by: Yan Wang, et al.
Published: (2022)

Meropenem Disposition in Neonatal and Pediatric Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy
by: Pavla Pokorná, et al.
Published: (2024)

Association between Extended Meropenem Regimen and Achievement of Aggressive PK/PD in Patients Receiving Continuous Renal Replacement Therapy for Septic AKI
by: Shinya Chihara, et al.
Published: (2024)

Intraosseous infusion of acyclovir in a neonate
by: Saverio De Marca, et al.
Published: (2022)

Clinical Outcomes and Safety of Meropenem-Colistin versus Meropenem-Tigecycline in Patients with Carbapenem-Resistant <i>Acinetobacter baumannii</i> Pneumonia
by: Jae-Min Park, et al.
Published: (2021)

Therapeutic hypothermia for neonatal encephalopathy with sepsis: a retrospective cohort study
by: Kei Lui, et al.
Published: (2022)

Meropenem pharmacokinetics in children: series of cases
by: Geisa Cristina da Silva Alves, et al.
Published: (2018)

Sepsis pada Neonatus (Sepsis Neonatal)
by: Titut S Pusponegoro
Published: (2016)

Neonatal sepsis
by: Angelica Dessì, et al.
Published: (2014)

Population Pharmacokinetics of Continuous-Infusion Meropenem in Febrile Neutropenic Patients with Hematologic Malignancies: Dosing Strategies for Optimizing Empirical Treatment against Enterobacterales and <i>P. aeruginosa</i>
by: Pier Giorgio Cojutti, et al.
Published: (2020)

A Regression Model to Predict Linezolid Induced Thrombocytopenia in Neonatal Sepsis Patients: A Ten-Year Retrospective Cohort Study
by: Lufen Duan, et al.
Published: (2022)

Community Acquired Neonatal SepsisA Cohort Study in Rural Southern India
by: Enakshi Ganguly, et al.
Published: (2020)

Measuring Creatinine Clearance Is the Most Accurate Way for Calculating the Proper Continuous Infusion Meropenem Dose for Empirical Treatment of Severe Gram-Negative Infections among Critically Ill Patients
by: Carla Troisi, et al.
Published: (2023)

Diagnosis Sepsis Neonatal
by: Zulfikri Zulfikri
Published: (2016)

BACTERIAL INFECTIONS IN THE NEONATE (NEONATAL SEPSIS)
by: Valeriu Popescu
Published: (2008)

Cyclic Pamidronate Infusion for Neonatal-onset Osteogenesis Imperfecta
by: Chia-Hsuan Lin, et al.
Published: (2014)

Effect of Different Approaches to Antimicrobial Therapy with Cefmetazole and Meropenem on the Time to Defervescence in Non-Severe Extended-Spectrum β-Lactamase-Producing <i>Escherichia coli</i> Bacteremia
by: Takanobu Hoshi, et al.
Published: (2023)

Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem
by: Maria Sanz Codina, et al.
Published: (2022)

Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant <i>Pseudomonas aeruginosa</i> Bloodstream Infections and/or Hospital-Acquired Pneumonia
by: Milo Gatti, et al.
Published: (2022)